Methemoglobin in critically ill septic patients

Atthaphong Phongphithakchai,Akinori Maeda,Yukiko Hikasa,Sofia Spano,Nuttapol Pattamin,Anis Chaba,Glenn Eastwood,Helen Young,Leah Peck,Rinaldo Bellomo
DOI: https://doi.org/10.1080/17520363.2024.2395246
Abstract:Aim: Higher nitric oxide (NO) levels correlate with adverse sepsis outcomes but are challenging to measure. Methemoglobin (MetHb), a measurable product of NO, has not been utilized for risk stratification.Methodology: All patients with sepsis admitted to the intensive care unit (ICU) that had at least one MetHb measurement within 24 h of ICU admission were retrospectively analyzed. We assessed the epidemiology and associations of MetHb with hospital mortality.Results: Among 7724 patients, 1046 qualified. Those with MetHb ≥1.6% showed significantly higher mortality and fewer days alive outside the hospital by day 28. MetHb levels ≥1.6% independently predicted increased 28-day mortality.Conclusion: Our findings suggest MetHb, easily obtainable from arterial blood gases, can significantly enhance sepsis risk stratification.
What problem does this paper attempt to address?